Welcome to our dedicated page for Alphatec Hldgs news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Hldgs stock.
Alphatec Holdings Inc (ATEC) delivers innovative spinal surgery solutions through advanced medical technologies designed to improve surgical outcomes. This news hub provides investors and healthcare professionals with essential updates on the company's latest developments in spinal fusion systems, regulatory milestones, and strategic partnerships.
Access authoritative information about ATEC's product innovations, including solutions for Posterior Cervical Fusion and Lateral Interbody Fusion procedures. Our curated collection features earnings announcements, clinical trial updates, and executive leadership changes - all critical for understanding the company's market position.
Key updates include:
- New product approvals and surgical device launches
- Financial performance reports and investor communications
- Collaborations with spine surgeons and research institutions
- Industry recognition and patent developments
Bookmark this page for ongoing access to verified information about Alphatec's contributions to spinal care technology. Check regularly for objective updates that matter to both clinical practitioners and investment decision-makers.
Alphatec Holdings, Inc. (ATEC) announced that CFO Jeff Black will present at the H.C. Wainwright BioConnect 2021 Conference from January 11-14, 2021. The pre-recorded presentation will be available on demand for 90 days starting January 11 at 6 A.M. ET. Interested viewers can access it via this link. ATEC focuses on innovative spine surgery solutions and aims to become the standard bearer in the industry.
Alphatec Holdings, Inc. (ATEC) has announced its agreement to acquire EOS imaging, SA for $79.7 million plus $37.2 million in debt. This all-cash deal aims to enhance ATEC's clinical performance and revenue growth by integrating EOS' advanced imaging technology with its AlphaInformatiX platform. The acquisition is expected to expand ATEC's market penetration and accelerate global growth, providing immediate access to EOS' 380-unit installed base. The deal has been approved by both companies' boards and is predicted to be accretive to ATEC's revenue and free cash flow in its first year post-closure.
Alphatec Holdings, Inc. (ATEC) announced its participation in several upcoming investor conferences, including the Stifel Healthcare Conference on November 18, 2020, and the Canaccord Genuity Medical Technologies Forum on November 19, 2020. CEO Pat Miles and CFO Jeff Black will attend, engaging with registered investors. A live audio webcast of their presentations will be available on the company's Investor Relations page, with recordings accessible for 90 days. ATEC is dedicated to advancing spine surgery solutions through innovative medical devices and technology.
Alphatec Holdings (ATEC) reported a 43% year-over-year revenue growth, totaling $41.2 million for Q3 2020, marking the eighth consecutive quarter of double-digit growth. U.S. revenue reached $40.1 million, with a gross margin of 72.9%. The company successfully closed a follow-on offering generating $107.7 million to support growth initiatives. ATEC anticipates full-year 2020 revenue between $143.5 million and $146.0 million, with expected 25% growth in U.S. revenue for 2021, despite potential impacts from COVID-19.
Alphatec Holdings (ATEC) announced the launch of the InVictus™ MIS Tower system, enhancing minimally invasive spinal surgery options. This advanced fixation platform aims to treat complex pathologies with improved surgical adaptability. The InVictus Tower features innovative components such as low-profile removable towers and integrates with the SafeOp™ Neural InformatiX System for real-time nerve monitoring. CEO Pat Miles emphasized the commitment to developing solutions that enhance surgical outcomes, aiming for increased adoption and loyalty among surgeons.
Alphatec Holdings (ATEC) announced the closing of its public offering of 13,142,855 common shares, raising approximately $115 million at a price of $8.75 per share. This includes the full exercise of underwriters' options for an additional 1,714,285 shares. The offering was managed by Morgan Stanley and Cowen, among others. The shares were offered under a previously declared effective shelf registration statement with the SEC. ATEC aims to innovate spine surgery through its subsidiaries, focusing on safe and effective treatment solutions.
Alphatec Holdings, Inc. (ATEC) announced a public offering of 11,428,570 shares of its common stock priced at $8.75 per share, aiming for gross proceeds of approximately $100 million. The offering includes a 30-day option for underwriters to purchase an additional 1,714,285 shares. The transaction is expected to close on October 16, 2020, pending customary conditions. This offering is part of ATEC's strategy to enhance its capital for further innovative developments in spine surgery solutions.
Alphatec Holdings, Inc. (ATEC) has initiated an underwritten public offering of $85 million in common stock. Additionally, ATEC may grant underwriters a 30-day option to purchase up to 15% more shares. All shares are being sold by ATEC, and the offering is subject to market conditions. Morgan Stanley and Cowen are the joint book-running managers for this offering. The shares are offered under a shelf registration statement filed with the SEC. No assurance is provided regarding the completion or terms of the offering.
Alphatec Holdings, Inc. (ATEC) reported preliminary financial results for Q3 2020, forecasting a U.S. revenue increase of 41% to 43% compared to Q3 2019, with total revenue between $40.7 million and $41.1 million. This marks the eighth consecutive quarter of double-digit growth, driven by new product adoption and the SafeOp neuromonitoring system, which accounted for over 70% of revenue. Despite growth, the company anticipates an operating loss of $12.0 million to $13.5 million. ATEC had approximately $41 million in cash as of September 30, 2020.
Alphatec Holdings, Inc. (ATEC) announced the launch of the Sigma TLIF Access System and InVictus Modular Pedicle Screw, aimed at enhancing the transforaminal lumbar interbody fusion (TLIF) clinical experience. These innovations integrate with the SafeOp Neural InformatiX system for a comprehensive spinal surgery approach. The Sigma TLIF Access System improves visualization and reproducibility of minimally invasive surgeries, while the InVictus system enhances fixation reliability. Both systems will be showcased at the virtual North American Spine Society meeting.